DILANTIN
BGP PHARMA ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of DILANTIN in Canada?
A shortage of DILANTIN 30MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 29, 2026), but it has not started yet.
Why is DILANTIN not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will DILANTIN be available again?
The manufacturer's estimated resolution date is November 10, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
DILANTIN
BGP PHARMA ULC
NOVO-PHENYTOIN CAP 100MG
NOVOPHARM LIMITED
TARO-PHENYTOIN
TARO PHARMACEUTICALS INC
DILANTIN INJ 50MG/ML
PARKE-DAVIS DIVISION, WARNER-LAMBERT CANADA INC.
PHENYTOIN SODIUM INJECTION USP
JUNO PHARMA CANADA INC.
PHENYTOIN SOIDUM INJECTION USP
PFIZER CANADA ULC
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2026-11-10
~36 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
00022772
Strength
30MG
Dosage Form
CAPSULE
Route
ORAL
Active Ingredient
PHENYTOIN SODIUM
Tier
Unrated
Last Updated
2026-09-29
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from BGP PHARMA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.